Solopov V N, Lunichkina I V
Klin Med (Mosk). 1990 Jun;68(6):77-82.
The study is made of the causes underlying a variety of obstruction syndrome presentation in bronchial asthma sufferers. Heterogenic pathogenesis of the disease is related to predominance of one of the three obstruction components: bronchospasm, inflammatory edema of the mucosa and sputum obturation of the airways as a result of defective expectoration. To quantify the components objectively, a special program of the patients' examination has been devised involving: 1) analysis of clinical symptoms, 2) pharmacological testing with selective and nonselective sympathomimetic agents and cholinolytics, 3) registration of the duration of the bronchial sputum evacuation (time of expectoration). Basing on relevant results, three variants of the obstruction are distinguished: bronchospastic, inflammatory-edematous++, obturation. The severity of bronchial obstruction progresses from the first to the third variant. Moreover, the efficacy of bronchospasmolytic drugs diminishes as shown by pharmacological tests: first of selective beta 2-agonists and cholinolytics followed by non-selective sympathomimetic agents which may be attributed to their additional alpha-stimulating action. In view of this the question of clinical significance of alpha-stimulated bronchial constriction is discussed with reference to original and literature data.
该研究针对支气管哮喘患者各种阻塞综合征表现的潜在病因展开。该疾病的异质性发病机制与三种阻塞成分之一的优势有关:支气管痉挛、黏膜炎症性水肿以及由于咳痰功能缺陷导致的气道痰液阻塞。为了客观地量化这些成分,设计了一个特殊的患者检查方案,包括:1)临床症状分析;2)使用选择性和非选择性拟交感神经药及胆碱能阻滞剂进行药理学测试;3)记录支气管痰液排出的持续时间(咳痰时间)。基于相关结果,区分出三种阻塞类型:支气管痉挛型、炎症 - 水肿型++、阻塞型。支气管阻塞的严重程度从第一种类型发展到第三种类型逐渐加重。此外,药理学测试表明,支气管解痉药物的疗效逐渐降低:首先是选择性β2激动剂和胆碱能阻滞剂,其次是非选择性拟交感神经药,这可能归因于它们额外的α刺激作用。鉴于此,结合原始数据和文献资料,讨论了α刺激引起的支气管收缩的临床意义问题。